9845sek
1,0 %
Date:2025-11-07Time:18:00:00Latest report:Q3-2025List:Mid CapTicker:BIOG B
Market Cap:9 959 msekEnterprise Value:9 231 msekNet Sales:1 462 msekEarnings:315,9 msekEmployees:0ISIN:SE0017769995
Ratios
10-year key figure history for BioGaia turnover, profit, dividend, equity, PE and PB.
Stockprice
Price movement for BioGaia with index and moving average MA50 and MA200.
Stockprice:98,45
MA50:104,92
MA200:107,04
Price/MA200:-8,0 %
RSI (14):30,2
Price/MA50:-6,2 %
Description
BioGaia is a biotechnology company operating in the pharmaceutical industry and focuses on the development, manufacturing and distribution of probiotics for health and well-being. The company's products are aimed at individuals and healthcare institutions. The business is global with a primary presence in Europe, North America and Asia. BioGaia was founded in 1990 and is headquartered in Stockholm.